Pyoderma gangrenosum in a patient with bullous systemic lupus erythematosus

European Journal of Dermatology

Volumn 12, Issue 5, 2002, Pages 485-487

  Sakamoto, Taiko ^a   Hashimoto, Takashi ^a   Furukawa, Fukumi ^a  

^a FUJIEDA MUNICIPAL GENERAL HOSPITAL   (Japan)

Author keywords

Bullous systemic lupus erythematosus; Cyclosporine; Pyoderma gangrenosum; Type VII collagen

Indexed keywords

ANTIBIOTIC AGENT; COLLAGEN TYPE 7; CYCLOSPORIN; DAPSONE; IMMUNOSUPPRESSIVE AGENT; LYSOZYME CHLORIDE; MIZORIBINE; PREDNISOLONE; RETINOIC ACID DERIVATIVE; STEROID;

ADULT; ARTICLE; BULLOUS SKIN DISEASE; BULLOUS SYSTEMIC LUPUS ERYTHEMATOSUS; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; PYODERMA GANGRENOSUM; SKIN BIOPSY; SKIN MANIFESTATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

CYCLOSPORINE; DAPSONE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MIDDLE AGED; PYODERMA GANGRENOSUM; SEVERITY OF ILLNESS INDEX; SKIN DISEASES, VESICULOBULLOUS; TREATMENT OUTCOME;

EID: 0036751563     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ryan TJ. Cutaneous vasculitis. In: Champion RH, Burton JL, Ebring FJG, eds. Textbook of Dermatology, Oxford, Blackwell Scientific Publications, 1992: 1992-27.
2. Powell FC, Schroeter AL, Su WPD, Perry HO. Pyoderma gangrenosum: a review of 86 patients. Q J Med 1985; 55: 173-86.
3. Johnson ML, Wilson HTH. Skin lesions in ulcerative colitis. Gut 1969; 10: 255-63.
4. Stolman LP, Rosenthal D, Yaworsky R, et al. Pyoderma gangrenosum and rheumatoid arthritis. Arch Dermatol 1975; 111: 1020-3.
5. Kramer N, Berman EL, Rosenstein ED. Pyoderma gongrenosum complicating Felty's syndrome. J Rheumatol 1990; 17: 1079-82.
6. Gilman AL, Cohen BA, Urbach AH, et al. Pyoderma gangrenosum as a manifestation of leukemia in childhood. Pediatrics 1988; 81: 846-8.
7. Ho KKL, Otridge B, Vandenbera E, et al. Pyoderma gangrenosum polycythemia rubra vera, and the development of leukemia. J Am Acad Dermatol 1992; 27: 804-8.
8. Byrne JPH, Hewitt M, Summerly R. Pyoderma gangrenosum associated wth chronic active hepatitis: report of two cases. Arch Dermatol 1976; 112: 1297-301.
9. Gammon WR, Briggaman RA. Bullous eruption of systemic lupus erythematosus. In: Wojnarowska F, Briggaman RA, eds. Management of blistering disease. London: Chapman and Hall Ltd, 1990: 263-75.
10. Gammon WR, Briggaman RA. Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder. J Invest Dermatol 1993; 100 (suppl.): 28s-34s.
11. Rappersberger K, Tshachler E, Tani M, Wolff K. Bullous disease in systemic lupus erythematosus. J Am Acad Dermatol 1989; 21: 745-52.
12. Olson K. Pyoderma gangrenosum with systemic lupus erythematosus. Acta Derm Venereol (Stockh) 1971; 51: 233-4.
13. Pinto GM, Cabecas MA, Riscado M, et al. Pyoderma gangrenosum associated with systemic lupus erythematosus: response to pulse steroid therapy. J Am Acad Dermatol 1991; 24: 818-21.
14. Grob JJ, Bonerandi JJ. Cutaneous manifestations associated with the presence of the lupus anticoagulant: a report of two cases and review of the literature. J Am Acad Dermatol 1986; 15: 211-9.
15. Harvath L, Yancey KB, Katz SI. Selective inhibition of neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones. J Immunol 1986; 137: 1305-11.
16. Altman J, Mopper C. Pyoderma gangrenosum treated with sulfone drugs. Minn Med 1966; 49: 22-6.
17. Soto LD. Diaminodiphenylsufone and steroid in the treatment of pyoderma gangrenosum. Int J Dermatol 1970; 9: 293-300.
18. Curley PK, Macfarlane AW, Vickers CFH. Pyoderma gangrenosum treated with cyclosporine A. Br J Dermatol 1985; 113: 601-4.
19. Elgart G, Stuver P, Larson K, et al. Treatment of pyoderma gangrenosum with cyclosporine: results in seven patients. J Am Acad Dermatol 1991; 24: 83-6.
20. Cardinali C, Giomi B, Caproni M, Fabbri P. Malignant pyoderma responding to cyclosporine. Eur J Dermatol 2001; 11: 595-6.